Model Bioptx -Healthcare Sensing Platform
By enabling continuous, real-time, non-invasive monitoring of a wide range of biomarkers, the Bioptx product line has the potential to transform the way that healthcare providers offer care to their patients.
Here is an example of some key insights that Bioptx products could provide at different stages of patient care.
- Non-invasive, continuous monitoring
- Ability to track baselines & trends
- Potential “early warnings” (e.g., changes in baseline)
- Peace-of-mind connection to healthcare provider
- More effective triage and monitoring capabilities
- Expanded paramedic capacity to prioritize administration of care
- Integration with hospital system to enable advance triage and preparation for ER staff
- Baseline patient monitoring with minimal staff time/intervention
- Proactive disease management
- Multiple patient monitoring capabilities displayed at a central nursing station
- Continuous monitoring of key indicators of recovery
- Possible earlier warning of complications (vs. standard methods)
- Quicker patient discharge (based on holistic biomarker view)
The Bioptx sensing wristband will provide an all-in-one solution for measuring a variety of key biomarkers — non-invasively — with the potential to provide real-time insights into personal health and well-being.
Bioptx Baseline
Featuring Rockley’s unique photonics-based lasers, Bioptx Baseline products will provide a continuous look into a person’s general wellness.
Bioptx Pro
Incorporating a more advanced suite of sensors, the Bioptx Pro line will enable the measurement of several additional biomarkers, often helpful for monitoring more complex health conditions.
The Bioptx product line will include a range of hardware and software solutions that enable continuous, non-invasive, and real-time monitoring of multiple biomarkers, from a wearable biosensing wristband to cloud analytics and artificial intelligence (AI).
The Bioptx line will also feature additional cloud-based subscription services that enhance the capabilities of the biosensing platform, potentially enabling a new class of healthcare applications.